Fundación Instituto de Inmunología de Colombia (FIDIC)

Colombia · 42 Employees
Manuel Elkin Patarroyo (born in 1946) received his M.D. degree from the Universidad Nacional de Colombia (National University of Colombia, School of Medicine) in 1971, where he is Full Professor for Molecular Pathology. He did postdoctoral studies at Rockefeller University in the United States with Professor Henry Kunkel and on Tumor Immunology at Karolinska Institute, Sweden, with Professor George Klein. In 1976, he founded the Instituto de Inmunología at the San Juan de Dios Hospital, fully devoted to the development of chemically synthesized vaccines, with malaria being one of them, with the advice of Professors Bruce Merrifield and David Andreu (Rockefeller University) and Professor Richard Lerner (Scripps Research Institute). The first chemically synthesized vaccine against this scourging disease was published in Nature in 1987, followed by a large series of clinical and field trials in different parts of the world that allowed the conclusion of the feasibility of chemically synthesized vaccines. He has received numerous awards, including the Award of the Third World Academy of Science (TWAS) in 1988, the Prince of Asturias Award in Science and Technology (Spain) in 1994, the Robert Koch Award (Germany) in 1994, the Medicin de l'année Award (France) in 1995, the Edinburgh Medal (England) in 1995, the National Science Award (Colombia) in 1986, 1984, 1982, and 1978, and 26 Honoris Causa Doctor degrees from different universities throughout the world. He is founder and current director of the Fundación Instituto de Inmunología de Colombia since 2001

概述

国家 Colombia
成立时间 1976
总部 Bogota, Colombia
电话号码
网站 http://www.fidic.org.co
LinkedIn http://www.linkedin.com/company/fidic-colombia
Twitter
Facebook
员工数 42
行业 research,
简介 Manuel Elkin Patarroyo (born in 1946) received his M.D. degree from the Universidad Nacional de Colombia (National University of Colombia, School of Medicine) in 1971, where he is Full Professor for Molecular Pathology. He did postdoctoral studies at Rockefeller University in the United States with Professor Henry Kunkel and on Tumor Immunology at Karolinska Institute, Sweden, with Professor George Klein. In 1976, he founded the Instituto de Inmunología at the San Juan de Dios Hospital, fully devoted to the development of chemically synthesized vaccines, with malaria being one of them, with the advice of Professors Bruce Merrifield and David Andreu (Rockefeller University) and Professor Richard Lerner (Scripps Research Institute). The first chemically synthesized vaccine against this scourging disease was published in Nature in 1987, followed by a large series of clinical and field trials in different parts of the world that allowed the conclusion of the feasibility of chemically synthesized vaccines. He has received numerous awards, including the Award of the Third World Academy of Science (TWAS) in 1988, the Prince of Asturias Award in Science and Technology (Spain) in 1994, the Robert Koch Award (Germany) in 1994, the Medicin de l'année Award (France) in 1995, the Edinburgh Medal (England) in 1995, the National Science Award (Colombia) in 1986, 1984, 1982, and 1978, and 26 Honoris Causa Doctor degrees from different universities throughout the world. He is founder and current director of the Fundación Instituto de Inmunología de Colombia since 2001

技术

Google Analytics

Analytics and Tracking

常见问题

Fundación Instituto de Inmunología de Colombia (FIDIC) 在哪里?

Fundación Instituto de Inmunología de Colombia (FIDIC) 的总部位于 Bogota, Colombia

Fundación Instituto de Inmunología de Colombia (FIDIC) 的电话号码是多少?

Fundación Instituto de Inmunología de Colombia (FIDIC) 的电话号码是

Fundación Instituto de Inmunología de Colombia (FIDIC) 的官方网站是什么?

Fundación Instituto de Inmunología de Colombia (FIDIC) 的公司官方网站是 http://www.fidic.org.co

Fundación Instituto de Inmunología de Colombia (FIDIC) 是做什么的?

Fundación Instituto de Inmunología de Colombia (FIDIC) 的业务有哪些?

immunology,peptide synthesis,recombinant proteins,vaccines,tuberculosis,malaria,monoclonal antibodies,receptorligand interactions

Fundación Instituto de Inmunología de Colombia (FIDIC) 的年收入是多少?

Fundación Instituto de Inmunología de Colombia (FIDIC) 的收入是 0美元

Fundación Instituto de Inmunología de Colombia (FIDIC) 有多少员工?

Fundación Instituto de Inmunología de Colombia (FIDIC) 有 42 名员工

Fundación Instituto de Inmunología de Colombia (FIDIC) 属于哪个行业?

Fundación Instituto de Inmunología de Colombia (FIDIC) 从事以下行业: research

Fundación Instituto de Inmunología de Colombia (FIDIC) 使用什么技术?

Fundación Instituto de Inmunología de Colombia (FIDIC) 使用的一些流行技术包括: Google Analytics

如何联系 Fundación Instituto de Inmunología de Colombia (FIDIC)?

Fundación Instituto de Inmunología de Colombia (FIDIC) 联系信息: 电话号码:， 网站:http://www.fidic.org.co， 邮箱：ema***@***.com

Fundación Instituto de Inmunología de Colombia (FIDIC) 的社交媒体链接是什么?

Fundación Instituto de Inmunología de Colombia (FIDIC) 领英：http://www.linkedin.com/company/fidic-colombia,fackbook：,twitte:

Fundación Instituto de Inmunología de Colombia (FIDIC) 是一家上市公司吗?

不是

Fundación Instituto de Inmunología de Colombia (FIDIC) 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 Fundación Instituto de Inmunología de Colombia (FIDIC)?

Fundación Instituto de Inmunología de Colombia (FIDIC) 有 0 家投资者,包括 。

管理层

Manuel Murillo

Director

员工

Jennifer Lambrano

Investigador

Maria Pena

Coordinadora de Sistemas de Gestión

Jhoan Martin

Investigador

Jonathan Castellanos

Investigador del Grupo Funcional de Tuberculosis

Rafael Jaramillo

Asistente de investigación- Joven investigador Colciencias

外贸获客 查找关键决策人

10亿+海关交易数据，1.2亿企业数据，2亿+企业联系人数据，1000千万真实采购商。覆盖200+个国家及地区，95%外贸重点拓展市场，可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少，成就更大，销售更聪明

查找更多 B2B 联系人，丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google